Catalina Capital Group LLC grew its holdings in The Cigna Group (NYSE:CI – Free Report) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,637 shares of the health services provider’s stock after acquiring an additional 56 shares during the period. Catalina Capital Group LLC’s holdings in The Cigna Group were worth $452,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the business. IFG Advisors LLC raised its holdings in The Cigna Group by 4.6% in the 3rd quarter. IFG Advisors LLC now owns 699 shares of the health services provider’s stock worth $242,000 after purchasing an additional 31 shares during the period. McClarren Financial Advisors Inc. raised its stake in shares of The Cigna Group by 4.7% in the third quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider’s stock worth $240,000 after buying an additional 31 shares during the period. Castle Rock Wealth Management LLC lifted its position in shares of The Cigna Group by 0.5% during the 3rd quarter. Castle Rock Wealth Management LLC now owns 6,651 shares of the health services provider’s stock valued at $2,263,000 after buying an additional 34 shares in the last quarter. Adero Partners LLC increased its holdings in The Cigna Group by 4.5% in the 3rd quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after acquiring an additional 34 shares in the last quarter. Finally, Waldron Private Wealth LLC increased its holdings in The Cigna Group by 1.0% in the 3rd quarter. Waldron Private Wealth LLC now owns 3,651 shares of the health services provider’s stock worth $1,265,000 after acquiring an additional 35 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
The Cigna Group Price Performance
The Cigna Group stock opened at $293.99 on Monday. The firm has a market capitalization of $81.77 billion, a PE ratio of 24.02, a price-to-earnings-growth ratio of 0.97 and a beta of 0.54. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The firm has a 50-day moving average price of $294.40 and a 200-day moving average price of $324.33. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.
The Cigna Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.05%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date of this dividend is Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is 45.75%.
Analysts Set New Price Targets
A number of equities analysts have weighed in on CI shares. Oppenheimer dropped their price target on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research report on Friday. Morgan Stanley cut their price target on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research note on Friday. Stephens lowered their price objective on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research report on Friday. Cantor Fitzgerald cut their target price on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Royal Bank of Canada lowered their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $380.27.
View Our Latest Stock Report on CI
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than The Cigna Group
- Business Services Stocks Investing
- 3 Underrated Robotics Stocks Poised for Major Growth
- When to Sell a Stock for Profit or Loss
- Reshoring Riches: Investing in Made in America 2.0
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 REITs to Watch as Interest Rates Keep Falling
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.